There is no disease specific treatment for<unk> . Anti-inflammatory medications, specifically tocilizumab (an interleukin-6 receptor inhibitor), has been shown to improve inflammation and pain in some patients. Bone marrow transplant may improve granulomas (small masses of inflamed tissue) and inflammation in patients with little or no lung or nervous system complications. Supportive therapies such as physical therapy, respiratory support, and mobility aids may be required. Studies in cells and mice have shown proof-of-concept for enzyme replacement therapy for<unk> . Aceragen, a biopharmaceutical company, is currently developing an investigational enzyme replacement therapy.
Farber disease
Keshan disease
Akureyri disease
Batten disease
Borna disease
Menkes disease
Bosch-Boonstra-Schaaf optic atrophy syndrome
Karak syndrome